liquid-biopsy Downloads
16 downloads found
Ultra-sensitive somatic mutation detection from liquid biopsy samples. Designed specifically for detection of mutations from liquid biopsy samples, Spotlight Oncology Panels are turnkey solutions for Illumina sequencers, offering ultra-sensitive variant detection from low input quantities of DNA. ...
The Spotlight TP53 liquid biopsy NGS panel contains 21 amplicons with an average size of 140 bp that provides comprehensive coverage of all coding regions of TP53. ...
Finally, the promise of sensitive, accurate liquid biopsy analysis by NGS has been realized! ERASE-Seq uses inter-sample signal processing to eliminate background artifacts and random sequencing errors, all without the need for molecular barcodes. ...
The IsoFlux Liquid Biopsy System is designed to enable molecular analysis of tumor cells from a blood sample. ...
The Spotlight EGFR Liquid Biopsy NGS Pathway Panel offers contiguous coverage of EGFR and hotspot coverage of BRAF, KRAS, and NRAS, using a 17-amplicon design to generate multiplex libraries compatible with lllumina sequencing platforms. ...
The Spotlight Myeloid Panel combines content from peer-reviewed publications and other sources to offer comprehensive and exon-level hotspot coverage of 23 clinically-relevant genes implicated in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). Because of the high prevalence of myeloid variants in clonal hematopoiesis of indeterminate potential ...
RNAPro•SAL was developed as an easy to use and cost effective tool for the split sample collection of rich sources of RNA miRNA, mRNA and proteins found in saliva. The proprietary RNAPro•SAL kit provides two equivalent samples of saliva which total 1.0 mL of saliva in 1-3 minutes. These may be analyzed later for either RNA or protein components. A unique built in Sample Volume Adequacy ...
Designed specifically for detection of somatic mutations fromliquid biopsy samples, the Spotlight 59 Oncology Panel is aturnkeysolution for Illumina sequencers, offeringultra-sensitive variant detectionfrom low input quantities of DNA. ...
Push the boundaries of your in-house liquid biopsy capabilities with MSK-ACCESS® powered with SOPHiA DDM™, a decentralized version of the rigorously validated cell-free DNA (cfDNA) assay developed and regularly used in clinical routine by Memorial Sloan Kettering Cancer Center ...
NGS-based liquid biopsy is a rapidly evolving application that requires accurate and precise reference standards. The Twist Pan-cancer Reference Standard is a high-quality, standardized control for use in the research and development of NGS-based liquid biopsy assays. This reference standard is ideal for establishing the analytical limit of detection (LoD) for specific cancer variants and as a ...
MSK-ACCESS® powered with SOPHiA DDM™ is a decentralized version of the highly validated liquid biopsy assay developed and routinely used by Memorial Sloan Kettering Cancer Center (MSK) 1,2, involving the deep sequencing (~20,000x) of 146 key cancer-associated genes. Powered by the advanced features of the SOPHiA DDM Platform, the genomic application’s sample-to-report workflow ...
OncoFOLLOW: The first personalised liquid biopsy in the market. Monitor the progression and detect lack of response. OncoFOLLOW is a test based on the analysis of circulating tumor DNA in blood. It is used to monitor the progression of the tumor (burden of the disease) and to detect lack of response or resistance to treatment as soon as it appears. This assay is customised for each patient, as it ...
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer ...
Pure•SAL was developed for the controlled and standardized collection of RNA or protein biomarkers from oral fluid specimens for subsequent stabilization and analysis in life science and research applications. The Pure•SAL Oral Specimen Collection Kit provides a simple non-invasive and rapid platform for isolating “liquid biopsy” specimens including cell free DNA, cell free ...
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization, and transport of venous whole blood samples for use in conjunction with cell-free DNA next-generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT ...
Biocept’s Target Selector™ molecular assay kits detect key oncogene mutations through the analysis of both Formalin-Fixed Paraffin-Embedded (FFPE) tissue gained from surgical biopsies as well as circulating tumor DNA (ctDNA) gained from blood-based liquid biopsies. The EGFR pathway can include mutations that are among the most frequently evaluated biomarkers for lung ...
ByBiocept